Keyphrases
South Africa
100%
Tertiary Hospital
47%
Antimicrobial Stewardship
47%
Antibiotics
37%
Pharmacist
36%
Influenza
34%
Tuberculosis
32%
Drug Delivery
31%
Migraine Headache
31%
Common Cold
31%
Pediatric Tuberculosis
31%
Gastroesophageal Reflux Disease
31%
Patient Safety Culture
31%
Reconstitutable
31%
Solid Dispersion
31%
Pyrazinamide
31%
Back Pain
31%
Atopic Dermatitis
31%
Imipenem
31%
Critically Ill Patients
31%
Headache
25%
Pharmaceutical Formulations
25%
Causal Factors
23%
Motility
23%
Antacids
23%
Inhibitor Agent
23%
Proton Pump Inhibitors
23%
Pharmacotherapeutic Management
23%
Cytoprotective Agents
23%
Acid Suppressant
23%
Irritation
23%
Histamine-2 Receptor Antagonists (H2RA)
23%
Acid Production
23%
Opioid Analgesics
23%
Sun Protection Factor
23%
Patient Safety
23%
Pharmaceutics
23%
Photoprotective Activity
22%
Rifampicin
21%
Fever
21%
Injectable Formulation
19%
Polyol
19%
Solubility Enhancement
19%
Therapeutic Agents
19%
Pediatric
19%
Viral Infection
19%
Sinusitis
18%
Therapeutic Drug Monitoring
18%
Polymer-based
18%
Over-the-counter Drugs
17%
Virus
17%
Mental Health
17%
Antimicrobial
17%
Sunscreen
17%
Recent Advances
16%
Orodispersible
15%
Design Optimization
15%
In Silico Characterization
15%
Dry Eye
15%
Nanoengineering
15%
Engineering Approach
15%
Crystal Engineering
15%
Crystalline Formulation
15%
Neutropaenia
15%
Physical Stability
15%
Quality by Design
15%
In-process
15%
In Vitro Quality
15%
Ethyl Cellulose
15%
COVID-19 Guidelines
15%
COVID-19
15%
Opioid Metabolism
15%
Low Back Pain Management
15%
Cross-linked Gel
15%
Unit Level
15%
Pharmacist Perspectives
15%
Dissolution Enhancement
15%
Treatment Options
15%
Multifunctional Ingredients
15%
Buddleja Saligna
15%
Helichrysum Odoratissimum
15%
Methodical Design
15%
Orodispersible Formulation
15%
Striae
15%
Safety Assessment
15%
Oil Formulation
15%
Striae Distensae
15%
Cosmetic Oil
15%
Sustainable Access
15%
Missing Components
15%
Facial Adiposity
15%
Rotavirus Disease
15%
Gastroesophageal Reflux
15%
Severe Headache
15%
Acute Attack
15%
Classification Treatment
15%
Recurrence Rate
15%
Prophylactic Treatment
15%
Classification Management
15%
Abortive Treatment
15%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
86%
Infection
45%
Isoniazid
45%
Influenza
37%
Antiinfective Agent
35%
Pyrazinamide
31%
Gastroesophageal Reflux
31%
Migraine
31%
Backache
31%
Atopic Dermatitis
31%
Imipenem
31%
Antibiotics
30%
Drug Delivery System
29%
Dosage Forms
27%
Pharmacotherapy
27%
Drug Release
24%
Coronavirinae
22%
Excipient
21%
Sinusitis
21%
Polyol
21%
Headache
20%
Adverse Event
19%
Rifampicin
19%
High Performance Liquid Chromatography
19%
Therapeutic Drug Monitoring
17%
Bioavailability
17%
Cosmetics
17%
Helichrysum
15%
Dry Eye
15%
Crystal Engineering
15%
Drug Stability
15%
Granulocyte Colony Stimulating Factor
15%
Pharmacogenetics
15%
Low Back Pain
15%
Central Nervous System Drug
15%
Controlled Drug Release
15%
Central Nervous System Disease
15%
Buddleja
15%
Stria
15%
Rotavirus
15%
Cytoprotective Agent
15%
Proton Pump Inhibitor
15%
Histamine H2 Receptor Antagonist
15%
Antacid Agent
15%
Acid
15%
Radiation Exposure
15%
Common Cold
15%
Dolutegravir
15%
Carbohydrates
15%
Fluorodeoxyglucose
15%
Opiate
15%
Reverse Phase High Performance Liquid Chromatography
15%
Bone and Joint Infections
15%
Neutropenia
15%
Polyamide
15%
Tenofovir Disoproxil
15%
Neoplasm
15%
Sunscreen
15%
Pollen Allergy
15%
Lamivudine
15%
Chemotherapy
15%
Malignant Neoplasm
15%
Posttraumatic Stress Disorder
15%
Non Insulin Dependent Diabetes Mellitus
15%
Anxiety Disorder
15%
Maltitol
15%
Protoporphyrin Tin
15%
Polyacrylic Acid
15%
Poloxamer
15%
Ethyl Cellulose
15%
Xylitol
15%
Pharmacokinetics
13%
Biomaterial
13%
Non-Steroidal Anti-Inflammatory Drug
11%
Rotavirus Infection
10%
Non Prescription Drug
9%
Antivirus Agent
9%
Antibiotic Resistance
9%
Antimicrobial Resistance
9%
Prevalence
9%
Trough Level
9%
Tuberculostatic Agent
9%
Side Effect
7%
Tablet
7%
Recurrent Disease
7%
Neurologic Disease
7%
Nausea and Vomiting
7%
Pruritus
7%
Pathophysiology
7%
Radiopharmaceutical Agent
7%
Anticarcinogen
7%
Staphylococcus Aureus
7%
Film Coating
7%
Solid Formulation
7%
Intraperitoneal Injection
7%
Analgesic Agent
7%
Allergic Rhinitis
7%
Cilastatin
6%
HIV
6%
Muscle Relaxant Agent
6%